Table 2.
Baseline data on randomization, number of outcome events and mean duration of Follow-up
| EVT | CT | Total | |
|---|---|---|---|
| N = 42 | N = 38 | N = 80 | |
| Age - yr | |||
| Mean (SD) | 56 (10) | 54 (10) | 56 (10) |
| Range | 34 - 73 | 26 - 78 | 26 - 78 |
| Gender - % | |||
| Female | 60 | 71 | 65 |
| Male | 40 | 29 | 35 |
| Number of unruptured aneurysms (untreated) - % | |||
| 1 | 83 | 89 | 86 |
| 2 | 14 | 8 | 11 |
| History of SAH - % | |||
| Yes | 14 | 5 | 10 |
| No | 86 | 95 | 90 |
| Target aneurysm size - mm | |||
| Mean (SD) | 6 (2) | 7 (3) | 7 (3) |
| Range | 3 - 11 | 3 - 16 | 3 - 16 |
| Target aneurysm location - % | |||
| Posterior | 5 | 13 | 9 |
| Anterior | 95 | 87 | 91 |
| Ophthalmic region | 35 | 30 | 32 |
| Middle Cerebral artery | |||
| 25 | 30 | 29 | |
| (% for anterior normalized to 100%) | |||
| Outcome events | |||
| Number | 0 | 0 | 0 |
| Duration of follow-up - months | |||
| Mean (SD) | 14.6 (11.0) | 12.6 (9.4) | 13.6 (10.2) |
EVT = Endovascular therapy; CT = Conservative treatment